Retraction notice to "The role of ATG-7 contributes to pulmonary hypertension by impacting vascular remodeling" [Journal of Molecular and Cellular Cardiology 157C (2021) 1-13]
1 Department of Cardiac Surgery, Fujian Medical University Union Hospital, Fuzhou, China; Department of Toxicology, Fujian Center for Evaluation of New Drug, Fujian Medical University, Fuzhou, China.
2 Department of Cardiac Surgery, Fujian Medical University Union Hospital, Fuzhou, China; The Key Laboratory of Fujian Province University on Ion Channel and Signal Transduction in Cardiovascular Disease, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China; Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
3 School of Pharmacy, Fujian Medical University, Fuzhou 350122, China; Department of Toxicology, Fujian Center for Evaluation of New Drug, Fujian Medical University, Fuzhou, China.
4 The Key Laboratory of Fujian Province University on Ion Channel and Signal Transduction in Cardiovascular Disease, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China; Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
5 Department of Cardiac Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
6 Department of Cardiac Surgery, Fujian Medical University Union Hospital, Fuzhou, China; Department of Toxicology, Fujian Center for Evaluation of New Drug, Fujian Medical University, Fuzhou, China; Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.